April 19, 2016
La Jolla, CA
Patent practice in the life sciences is constantly evolving. The Federal Circuit has continued to face a plethora of issues that go the very heart of our patent system, including basic questions such as when subject matter is patentable, what are the presumptions in deciding validity, and even the appropriate standards of review from PTAB and district court proceedings. The PTAB, while initially slow to start with respect to pharmaceutical and biotech proceedings, has gained momentum and there are now a number of significant decisions in this area. And whether you are in a district court litigation or PTAB proceeding, selecting the right expert is vitally important to your success. Please join us as we address these issues and provide insight to help guide your practice.
Topics to be discussed include:
Speakers:
M. Paul Barker
Jonathan R. Davies, Ph.D.
Howard W. Levine
Jeffrey D. Smyth
Jennifer S. Swan
Time:
9:15 - 9:45 a.m.
Registration and Breakfast
9:45 a.m. – 2:00 p.m.
Workshop and Lunch
Who Should Attend:
General counsel and in-house patent counsel with responsibility for/interest in protecting a company’s intellectual property.
MCLE Credit:
Finnegan confirms that this activity has been certified for 3.0 hours of California MCLE. There is no charge to attend.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Webinar
Building a Strong ADC Patent Portfolio – From Prosecution and Litigation Perspectives
May 15, 2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.